|
Comments (Vagina)
|   |
|
Comments (Vagina)
| |
Response Options to “Histologic Type”
___ Squamous cell carcinoma, NOS
___ Squamous cell carcinoma, keratinizing
___ Squamous cell carcinoma, nonkeratinizing
___ Squamous cell carcinoma, basaloid
___ Squamous cell carcinoma, verrucous
___ Squamous cell carcinoma, warty
___ Squamous cell carcinoma, papillary
___ Adenocarcinoma, NOS
___ Mucinous carcinoma, NOS
___ Endometrioid carcinoma
___ Clear cell carcinoma
___ Mesonephric carcinoma
___ Adenosquamous carcinoma
___ Adenoid basal carcinoma
___ Small cell neuroendocrine carcinoma
___ Large cell neuroendocrine carcinoma
___ Undifferentiated carcinoma
___ Carcinosarcoma
___ Other histologic type not listed (specify): _________________________
___ Carcinoma, type cannot be determined
Note: Microinvasive/superficial invasive carcinoma is not currently a recognized entity in the vagina, and thus the term is not used.
Response Options to “Other Tissue/ Organ Involvement” (select all that apply)
Note: Any organ not selected is either not involved or was not submitted.
___ Not applicable
___ Not identified
___ Paravaginal tissues
___ Pelvic sidewall
___ Vagina, lower third
___ Bladder mucosa
___ Rectal mucosa
___ Other organs/tissue (specify): ________________
___ Cannot be determined (explain):_________________________
*Note: For upper two-thirds of the vagina, the following are considered regional lymph nodes: pelvic, parametrial, obturator, internal iliac (hypogastric), external iliac, common iliac, sacral, presacral, and para-aortic. For lower third of the vagina, the following are considered regional lymph nodes: inguinal and femoral. Any involved nonregional nodes should be categorized as metastases (pM1) and commented on in the distant metastasis section. Presence of isolated tumor cells no greater than 0.2 mm in regional lymph node(s) is considered N0 (i+). Reporting the number of lymph nodes with isolated tumor cells is required only in the absence of metastasis greater than 0.2 mm in other lymph nodes.